PubRank

Masayuki Tsuchiya

Author PubWeight™ 21.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J Biol Chem 2003 3.19
2 Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res 2004 2.34
3 Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer. Cancer Res 2008 1.35
4 Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells. Biochem Biophys Res Commun 2008 1.16
5 Apoptosis inducing bivalent single-chain antibody fragments against CD47 showed antitumor potency for multiple myeloma. Leuk Res 2004 1.16
6 Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target. Clin Cancer Res 2006 1.11
7 Generation of a humanized anti-glypican 3 antibody by CDR grafting and stability optimization. Anticancer Drugs 2010 1.04
8 A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells. Biochem Biophys Res Commun 2004 1.04
9 Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse. Pathol Int 2008 1.00
10 Viral envelope protein gp64 transgenic mouse facilitates the generation of monoclonal antibodies against exogenous membrane proteins displayed on baculovirus. J Immunol Methods 2007 0.96
11 A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environment. Cancer Res 2007 0.96
12 A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-beta. Biochem Biophys Res Commun 2003 0.95
13 Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma. Clin Cancer Res 2007 0.90
14 A novel therapeutic approach for thrombocytopenia by minibody agonist of the thrombopoietin receptor. Blood 2004 0.90
15 VH/VL interface engineering to promote selective expression and inhibit conformational isomerization of thrombopoietin receptor agonist single-chain diabody. Protein Eng Des Sel 2010 0.85
16 Recovery of functional peptide transporter PepT1 in budded baculovirus fraction. Protein Expr Purif 2005 0.81
17 Determination of concentration and binding affinity of antibody fragments by use of surface plasmon resonance. J Biosci Bioeng 2005 0.79
18 A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line. Int J Cancer 2003 0.78
19 Identification of a checkpoint modulator with synthetic lethality to p53 mutants. Anticancer Drugs 2011 0.76
20 2D7 diabody bound to the alpha2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells. Biochem Biophys Res Commun 2004 0.76
21 Low-loss deflection prism for a laser beam with Brewster angle. Appl Opt 2005 0.75